Skip to main content
. 2014 May 13;10(2):232–239. doi: 10.5114/aoms.2014.42573

Table III.

Proportions of TregFoxP3+ and Th17 (x¯ ± s,%) and the TregFoxP3+/Th17 ratio of the healthy control group and the NSCLC group

Variable Healthy control group (n = 18) NSCLC group (n = 26) Value of p
TregFoxP3+ 3.65 ±0.97 7.02 ±2.41 < 0.05
Th17 2.21 ±0.64 3.61 ±0.82 < 0.05
TregFoxP3+/Th17 1.54 ±0.45 1.92 ±0.51 < 0.05